Project Grant W81XWH2210568
Award Date
7/1/22
Completion Date
6/30/25
Dollars Obligated
$3M
Federal Agency
Medical Command
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02130, USA
Similar Awards
The Department of the Army Medical Command awarded a $1,657,861 project grant to H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. to develop adoptive T-cell therapy incorporating patient-specific tumor microenvironments for the treatment of bladder cancer. The grant was awarded on September 1, 2022 under the Military Medical Research and Development program (CFDA 12.420) and will support research activities through August 31, 2026. The Military Medical Research and...
The Department of the Army Medical Command awarded a $658,800 project grant to H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. to support research under the Military Medical Research and Development program (CFDA 12.420). The three-year project grant will fund research from September 2022 to August 2025 to decode resistance mechanisms to oncolytic virotherapy in muscle-invasive bladder cancer. The Military Medical Research and Development program aims to transform military and...
The Sloan-Kettering Institute for Cancer Research was awarded a $707,437 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2025 to enhance the immunogenicity of nectin-4 targeted therapy for the treatment of aggressive bladder cancer. The Military Medical Research and Development program supports basic, applied, and advanced biomedical...
The Department of the Army Medical Command awarded a $1,419,356 project grant to Brigham & Women's Hospital Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2021 through September 2025 to develop novel immunotherapy approaches to suppress cancer metastasis and recurrence in bone. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
This Project Grant award of $173,500.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by Health Research, Inc. at Roswell Park in Buffalo, NY to improve the efficacy of chemotherapy for small cell carcinomas of the bladder. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing innovative biomedical investigations that address critical health challenges. The award...
The U.S. Defense Health Agency awarded a $653,928 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct a 3-year research project titled "TARGETING DENDRITIC CELLS IN BLADDER CANCER IMMUNOTHERAPY". The grant, funded under the Military Medical Research and Development program (CFDA 12.420), will support MGH's biomedical research, including clinical trials and laboratory studies, to develop new treatments and diagnostics for...
H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. was awarded a $1,193,945 project grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund development of adoptive T-cell therapy incorporating patient-specific tumor microenvironments to treat bladder cancer from September 1, 2022 to August 31, 2026. The Military Medical Research and Development program supports biomedical research that transforms...
The Department of the Army Medical Command awarded Brigham & Women's Hospital Inc. a $130,698 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will support the development of the first targeted therapy for translocation renal cell carcinoma from August 15, 2022 to August 14, 2023. As the parent organization of the awardee, Partners Healthcare System Incorporated will oversee delivery of this innovative medical research effort to develop new...
This $646,252 Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports research to uncover cell intrinsic and extrinsic factors governing melanoma dormancy at single-cell resolution. The primary awardee, Trustees of Boston University, will conduct this advanced biomedical research. The University of Virginia will provide academic and technical resources, including experiments generating and validating...
The Department of the Army Medical Command awarded Brigham & Women's Hospital Inc. a $648,276 Project Grant under the Military Medical Research and Development program. The three-year award will fund research from September 2022 to September 2025 to target TFEB and TFE3 in renal tumorigenesis. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of transforming military and public health care through innovative...